Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
27.90%
↑ 104% above average
Average (26q)
-735.10%
Historical baseline
Range
High:1544.44%
Low:-21076.47%
Volatility
-3077.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 27.90% |
| Q2 2025 | -45.12% |
| Q1 2025 | -1.23% |
| Q4 2024 | -15.71% |
| Q3 2024 | 7.89% |
| Q2 2024 | 11.63% |
| Q1 2024 | -53.57% |
| Q4 2023 | 39.13% |
| Q3 2023 | -13.58% |
| Q2 2023 | 42.96% |
| Q1 2023 | -140.68% |
| Q4 2022 | -9.26% |
| Q3 2022 | -113.85% |
| Q2 2022 | 1544.44% |
| Q1 2022 | 63.51% |
| Q4 2021 | -85.00% |
| Q3 2021 | -11.11% |
| Q2 2021 | -21076.47% |
| Q1 2021 | 99.75% |
| Q4 2020 | -161.54% |
| Q3 2020 | 42.22% |
| Q2 2020 | -73.08% |
| Q1 2020 | -8.33% |
| Q4 2019 | 96.49% |
| Q3 2019 | -14.98% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |